Top

20-04-2024 | Denosumab | Case Report

Denosumab-induced bone changes in a child: a case report

Authors: Caroline Rutten, Claudia Martinez-Rios, Alan Daneman

Abstract

We present the case of a 9-year-old girl who developed striking bone changes following two years of denosumab therapy for giant cell lesions of the jaw.

Wang D, Tang X, Shi Q, et al (2023) Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review. Transl Pediatr 12:470–486. https://doi.org/10.21037/tp-22-276

Wang HD, Boyce AM, Tsai JY et al (2014) Effects of denosumab treatment and discontinuation on human growth plates. J Clin Endocrinol Metab 99:891–897. https://doi.org/10.1210/jc.2013-3081CrossRefPubMedPubMedCentral

Szymczuk V, Boyce A, Merchant N (2023) Metaphyseal sclerosis in a child with a giant cell tumour treated with denosumab. Lancet (London, England) 402:e4. https://doi.org/10.1016/S0140-6736(23)00915-7CrossRefPubMed

Dunnion S, Paterson A, Johnston R (2020) Dense sclerotic metaphyseal bands caused by denosumab therapy

Kobayashi E, Setsu N (2015) Osteosclerosis induced by denosumab. Lancet (London, England) 385:539. https://doi.org/10.1016/S0140-6736(14)61338-6CrossRefPubMed

Isojima T, Sims NA (2021) Cortical bone development, maintenance and porosity: genetic alterations in humans and mice influencing chondrocytes, osteoclasts, osteoblasts and osteocytes. Cell Mol Life Sci 78:5755–5773. https://doi.org/10.1007/s00018-021-03884-wCrossRefPubMed

Laor T, Clarke JP, Yin H (2016) Development of the long bones in the hands and feet of children: radiographic and MR imaging correlation. Pediatr Radiol 46:550–551. https://doi.org/10.1007/s00247-015-3513-7CrossRef

Fernández-Iglesias Á, Fuente R, Gil-Peña H, et al (2021) The Formation of the Epiphyseal Bone Plate Occurs via Combined Endochondral and Intramembranous-Like Ossification. Int J Mol Sci 22. https://doi.org/10.3390/ijms22020900

Sobacchi C, Abinun M (2022) Osteoclast-poor osteopetrosis. Bone 164:116541. https://doi.org/10.1016/j.bone.2022.116541CrossRefPubMed

10.

Boyce RW, Varela A, Chouinard L et al (2014) Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period. Bone 64:314–325. https://doi.org/10.1016/j.bone.2014.04.002CrossRefPubMed

11.

Chen N, Wu RWH, Lam Y et al (2023) Hypertrophic chondrocytes at the junction of musculoskeletal structures. Bone Rep 19:101698. https://doi.org/10.1016/j.bonr.2023.101698CrossRefPubMedPubMedCentral

Title: Denosumab-induced bone changes in a child: a case report
Authors: Caroline Rutten
Claudia Martinez-Rios
Alan Daneman
Publication date: 20-04-2024
Publisher: Springer Berlin Heidelberg
Keywords: Denosumab
Denosumab
giant cell tumor
Published in: Pediatric Radiology
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI: https://doi.org/10.1007/s00247-024-05895-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Denosumab-induced bone changes in a child: a case report

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content